|
Idiopathic |
· Most common · Chronic injury to type 2 pneumatocytes |
|
Medications |
· Amidoarone · Methotrexate · Bleomycin |
|
Systemic disease |
· Rheumatoid arthritis · Sarcoidosis |
|
Occupational |
· Asbestos · Silica · Dust · Mould |
|
Hx |
· SOB · Dry cough |
|
Ex |
· Fine end-inspiratory crackles |
|
Ix |
· HRCT |
|
Lung disease |
Risks: · T1RF: ↓FRC, impaired V/Q matching · T2RF: restrictive impairment, sensitivity to opioids · Pneumonia · Pneumothorax Prevention: · Analgesia: regional, opioid-sparing, APS-run · Reversal: rocuronium -> sugammadex · Ventilation: ↑RR, ↑i-time, ↓VT, careful FiO2 and PEEP (consider ICU ventilator) · Disposition: post-op HDU/ICU |
|
Right heart disease |
· i.e. pulmonary hypertension, RV failure · See elsewhere… |
|
Drug side effects |
· Immunosuppression -> risk of infection, wound breakdown · Adrenocortical suppression -> risk of Addisonian crisis |
https://www.anesthesiaconsiderations.com/restrictive-lung-disease-considerations
Feedback welcome at ketaminenightmares@gmail.com